abstract |
The present invention is a compound of the following formula (I) and a pharmaceutically acceptable salt thereof, a pharmaceutical composition comprising the compound of formula (I), and the compounds, salts and compositions used in the treatment of various diseases related to CRM1 activity Regarding the method: . |